ABVX Company Profile and Key Details

NASDAQ : ABVX

Abivax SA

$126.54

2.76+2.23%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Abivax S.A. (ABVX) stock surged +2.23%, trading at $126.54 on NASDAQ, up from the previous close of $123.78. The stock opened at $125.64, fluctuating between $123.45 and $129.18 in the recent session.

Stock Snapshot

123.78

Prev. Close

8.3B

Market Cap

123.45

Day Low

-22.32

P/E Ratio

-5.67

EPS (TTM)

-2.08

Cash Flow per Share

125.64

Open

65.57M

Number of Shares

129.181

Day High

87.65%

Free Float in %

4.06

Book Value

1.24M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 06, 2026	125.64	129.18	123.45	126.54	1.24M
May 05, 2026	124.25	125.36	119.70	123.78	1.26M
May 04, 2026	118.31	119.04	114.85	117.13	566.26K
Apr 30, 2026	108.49	117.72	108.12	117.38	1.19M
Apr 29, 2026	109.87	110.27	106.00	106.24	884.1K
Apr 28, 2026	111.79	114.41	109.77	109.87	599.71K
Apr 27, 2026	112.48	113.68	111.01	111.90	781.9K
Apr 23, 2026	115.26	116.51	112.77	113.00	569.42K
Apr 22, 2026	113.40	116.00	111.83	115.99	655.01K
Apr 21, 2026	115.01	116.99	111.28	111.43	721.96K
Apr 20, 2026	120.21	120.75	114.90	114.98	866.43K
Apr 17, 2026	125.11	125.72	119.79	120.16	1.18M
Apr 16, 2026	121.69	123.19	119.51	122.47	740.62K
Apr 14, 2026	122.17	127.44	121.03	125.80	934.57K
Apr 13, 2026	122.00	126.00	120.19	121.31	1.51M
Apr 10, 2026	126.00	128.42	122.55	126.14	997.84K
Apr 09, 2026	119.96	126.00	119.84	125.69	1.06M
Apr 08, 2026	120.30	120.75	117.00	118.96	437.15K
Apr 07, 2026	119.06	119.06	113.75	116.48	389.06K
Apr 06, 2026	117.89	120.00	117.00	119.47	297.06K

Contact Details

Paris, 75008

France

https://www.abivax.com 331 538 30841

About Company

ABIVAX Soci�t� Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Soci�t� Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.

Stock Peers

ARGX

12.85+1.62%

argenx SE$807.55 REGN

18.78+2.67%

Regeneron Pharmaceuticals, Inc.$721.05 UTHR

24.56+4.29%

United Therapeutics Corporation$596.76 MDGL

37.26+7.42%

Madrigal Pharmaceuticals, Inc.$539.73 VRTX

3.29+0.78%

Vertex Pharmaceuticals Incorporated$427.65 PRAX

4.77+1.43%

Praxis Precision Medicines, Inc.$338.07 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

1.89+0.63%

Alnylam Pharmaceuticals, Inc.$303.00 KRYS

4.42+1.55%

Krystal Biotech, Inc.$288.99 ASND

10.62+4.71%

Ascendis Pharma A/S$235.90

Frequently Asked Questions

What is the current Abivax S.A. (ABVX) stock price?

Abivax S.A. (NASDAQ: ABVX) stock price is $126.54 in the last trading session. During the trading session, ABVX stock reached the peak price of $129.18 while $123.45 was the lowest point it dropped to. The percentage change in ABVX stock occurred in the recent session was 2.23% while the dollar amount for the price change in ABVX stock was $2.76.

ABVX's industry and sector of operation?

The NASDAQ listed ABVX is part of Biotechnology industry that operates in the broader Healthcare sector. Abivax S.A. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ABVX?

No Data

How ABVX did perform over past 52-week?

ABVX's closing price is 2,163.68% higher than its 52-week low of $5.59 where as its distance from 52-week high of $148.83 is -14.98%.

How many employees does ABVX have?

Number of ABVX employees currently stands at 69.

Link for ABVX official website?

Official Website of ABVX is: https://www.abivax.com

How do I contact ABVX?

ABVX could be contacted at phone 331 538 30841 and can also be accessed through its website. ABVX operates from 5, rue de la Baume, Paris, 75008, France.

How many shares of ABVX are traded daily?

ABVX stock volume for the day was 1.24M shares. The average number of ABVX shares traded daily for last 3 months was 943.46K.

What is the market cap of ABVX currently?

The market value of ABVX currently stands at $8.30B with its latest stock price at $126.54 and 65.57M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	69
Beta	-0.1
Sales or Revenue	$4.62M
5Y Sales Change%	0.34%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	69
Beta	-0.1
Sales or Revenue	$4.62M
5Y Sales Change%	0.34%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ABVX Company Profile and Key Details

Abivax SA

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics